ues, and represented the United Kingdom on the Biologics
Working Party of the Committee for Medicinal Products for Human Use (CHMP)
at the European Medicines Agency (EMEA). He also worked as Senior Director,
Head of European Regulatory Affairs for Shire Human Genetic Therapies, Ltd.
Prior to that, Dr. Forsey worked for Pharmacia, Amgen, the National
Institute for Biological Standards and Control and the University of
London. In all, he brings more than 30 years of pharmaceutical,
governmental and research experience to his role with Kendle.
Dr. Forsey earned a doctorate in microbiology from the University of
London and a Bachelor of Science in microbiology from the University of
Surrey, England. A widely-published author, he is a registered member of
The Organisation for Professionals in Regulatory Affairs (TOPRA) and the
Drug Information Association (DIA).
Dr. Forsey is the latest member of an international team of
pharmaceutical, clinical and non-clinical biotechnology experts Kendle has
assembled with backgrounds encompassing regulatory agencies on three
continents, as well as experience working for a variety of pharmaceutical
companies and academic and research institutions.
Kendle International Inc. (Nasdaq: KNDL) is among the world's leading
global clinical research organizations and is the fourth-largest provider
of Phase II-IV clinical development services worldwide. We deliver
innovative and robust clinical development solutions - from first-in-human
studies through market launch and surveillance - to help the world's
biopharmaceutical companies maximize product life cycles and grow market
Our global clinical development business is focused on five regions -
North America, Europe, Asia/P
Page: 1 2 3 Related biology technology :1
|SOURCE Kendle International Inc.|
Copyright©2007 PR Newswire.
All rights reserved
. Kendle to Ring Opening Bell at NASDAQ Stock Market on August 222
. Kendle Marks 10th Anniversary as Public Company With NASDAQ Opening Bell Ceremony and Investor Day Event3
. Kendle to Present at Thomas Weisel Partners Healthcare Conference 20074
. Kendle to Present at Bear Stearns 20th Annual Healthcare Conference5
. Kendle to Present at the UBS Global Life Sciences Conference6
. Kendle to Present at the Natixis Bleichroeder Hidden Gems Conference7
. Kendle Invites You to Attend Its Third Quarter 2007 Earnings Conference Call and Webcast8
. Kendle Named Best CRO for Second Consecutive Year by Leading Global Pharmaceutical Publication Scrip9
. BioVex Appoints Dr. Thaddeus Pullano as VP, Quality Assurance10
. Codexis Appoints Singapore Laboratories Managing Director11
. Emisphere Technologies, Inc. Appoints Paul Lubetkin as Vice President and General Counsel